2CBecca, also known as 4-(4-bromo-2,5-dimethoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, is a serotonin receptor modulator of the phenethylamine, 2C, and N-benzylphenethylamine families. It is a cyclized phenethylamine analogue of the serotonergic psychedelic 25B-NBOMe in which the N-benzylethylamine side chain has been cyclized to form a tetrahydroisoquinoline ring. The drug shows affinity for the serotonin 5-HT2A and 5-HT2C receptors (Ki = 39–71nM and 267–850nM, respectively). 2CBecca was first described in the scientific literature by Michael Robert Braden of the lab of David E. Nichols at Purdue University in 2007.
See also Substituted methoxyphenethylamine Cyclized phenethylamine 2C-B-3PIP LPH-5 DEMPDHPCA-2C-D Z3517967757 2CJP 2CLisaB 2C-B-3PIP-NBOMe 2C-B-3PIP-POMe
References
External links 2CBecca - Isomer Design